Following the IOC's decision to exclude longboard from the Los Angeles 2028 programme, the ISA has issued an official statement reaffirming its commitment to the discipline, focusing on the ...

For the Argentinian official, Coventry's electoral victory marked "a signal" of sorts which could very well mark "the inclusion of longboard at the Los Angeles Games" while the surfing body plays ...

It’s February, people, and if you’re looking to snag a pair of the best boxing gloves to get a better-late-than-never start on your 2025 fitness resolutions, you’ve come to the right place.

Wearing winter gloves while using a touchscreen phone often goes about as smoothly as trying to read a book in the dark: you can’t use one without making the other basically obsolete.

The Velotoze Neoprene gloves are very comfortable to wear and maintain a good level of dexterity. The neoprene handles rain and spray very well, and your hands might be wet but they'll be warm.

THE BEST SKI GLOVES will help ensure that your time spent outdoors won't be ruined by colder weather. Winter snowsports, in general, offer some of the best forms of testing endurance, enjoyment of ...

Denmark’s Lundbeck is set to acquire Longboard Pharmaceuticals for about $2.5 billion. California-based Longboard has a small molecule, bexicaserin, in late-stage clinical trials for certain ...

Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company whose lead asset is in late-stage clinical ...

(RTTNews) - Danish pharmaceutical company H. Lundbeck A/S (HLUKY.PK, HLUKF.PK) and Longboard Pharmaceuticals, Inc. (LBPH), announced Monday an agreement for Lundbeck to acquire Longboard $60 per ...

H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The Danish pharmaceutical company is offering ...

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck's $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

October 14, 2024--(BUSINESS WIRE)--H. Lundbeck A/S (Lundbeck) and Longboard Pharmaceuticals, Inc (NASDAQ: LBPH) (Longboard) today announced an agreement for Lundbeck to acquire Longboard.